| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/22/2004 | EP1458856A1 Isolated phages and their use in food or pet food products |
| 09/22/2004 | EP1458854A2 Cellular compositions and methods of making and using them |
| 09/22/2004 | EP1458852A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 09/22/2004 | EP1458850A1 Periosteal distraction |
| 09/22/2004 | EP1458849A2 Differentiation of human embryonic stem cells in avian embryos |
| 09/22/2004 | EP1458406A1 A method of treatment and agents useful for same |
| 09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458334A1 Yeast-based curative and care product and method for making same |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1259598B1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/22/2004 | EP1207859B1 Oral form of administration containing probiotic micro-organisms |
| 09/22/2004 | EP1135161B1 Chemotherapeutic composition and method |
| 09/22/2004 | EP1045704B1 Methods for quenching pathogen inactivators in biological materials |
| 09/22/2004 | EP0910624B1 Process for producing and multiplying lymphocytes |
| 09/22/2004 | EP0809433B1 Systems and methods for removing free and entrained contaminants in plasma |
| 09/22/2004 | EP0771355B1 A method for large scale plasmid purification |
| 09/22/2004 | EP0706575B1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 09/22/2004 | CN1531591A Method for introducing nucleic acids and other biologially active molecules into nucleus of higher exkaryotic cells by means of electrical current |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531553A WT1 modified peptide |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531438A Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 09/22/2004 | CN1531422A Gene delivery formulations and methods for treatment of ischemic conditions |
| 09/22/2004 | CN1531398A Animal feed supplement containing D-pantothenic acid and/or its salts, improved method for production thereof, and its use |
| 09/22/2004 | CN1530103A Health article for ensuring normal sleep |
| 09/22/2004 | CN1530097A Use of trivalency chromium in preparation of drug against allergic rhinitis |
| 09/22/2004 | CN1167460C Medicine for infant to invigorate sipleen and expel stagnation and its preparing process |
| 09/22/2004 | CN1167459C Nutritive healthy food with functions of reducing blood fat and delaying senility and its preparation |
| 09/22/2004 | CN1167456C Compound paste of donkey-skin gelatin for enriching blood |
| 09/22/2004 | CN1167454C Chinese medicine for detoxication and its preparation |
| 09/22/2004 | CN1167452C Medicine for AIDS |
| 09/22/2004 | CN1167451C External applied medicine for scald and burn, and its production and use |
| 09/22/2004 | CN1167450C Medicine for hyperosteogeny and bone retromophosis and its preparation |
| 09/22/2004 | CN1167440C Chinese herbal medicinal composition for smoothing liver and detoxication |
| 09/22/2004 | CN1167437C Medicine for curing heloma and planter wart |
| 09/22/2004 | CN1167435C Chinese medicine for treating male veneral diseases |
| 09/22/2004 | CN1167431C Chinese medicine plaster for treating mastoproliferation and its preparation |
| 09/22/2004 | CN1167430C Broad-spectrum antibacterial ointment for treating deep burn |
| 09/22/2004 | CN1167429C Medicine for treating cardiovascular disease to prevent coronary thrombosis and myocardial ischemia |
| 09/22/2004 | CN1167428C External applied ointment for treating hyperosteogeny |
| 09/22/2004 | CN1167427C Preparing method of life prolonging preparation |
| 09/22/2004 | CN1167426C Preparation of zymolite of blue scad to improve function of brain cells |
| 09/21/2004 | US6794368 Composition and method for inducing apoptosis in prostate cancer cells |
| 09/21/2004 | US6794359 Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same |
| 09/21/2004 | US6793939 Tissue graft composition comprising liver basement membrane; graft composition can be implanted to replace or induce repair of damaged or diseased tissues |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793921 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 09/21/2004 | US6793918 Genetic engineering; insertion of adenovirus vectors into cells |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/16/2004 | WO2004078957A1 DENDRITIC CELL PRESENTING α-GLYCOSYLCERAMIDE DERIVATIVE AND ANTIGEN AND USABLE IN SUPPRESSING IMMUNE RESPONSE |
| 09/16/2004 | WO2004078928A2 T cell regulation |
| 09/16/2004 | WO2004078927A2 Progenitor cells and methods of using same |
| 09/16/2004 | WO2004078917A2 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
| 09/16/2004 | WO2004078915A2 Cell culture |
| 09/16/2004 | WO2004078217A1 Bone calcification promoter |
| 09/16/2004 | WO2004078209A1 Composition and method for the treatment and prevention of enteric bacterial infections |
| 09/16/2004 | WO2004078206A1 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 09/16/2004 | WO2004078188A1 COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION |
| 09/16/2004 | WO2004078187A1 Dried blood plasma product |
| 09/16/2004 | WO2004078022A2 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | WO2004067697A3 Icos+ suppresser t cells |
| 09/16/2004 | WO2004050706A3 Regulatory t-cells |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004030631A3 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 09/16/2004 | WO2003097809A3 Sterilized xenograft tissue |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | WO2002100827A3 Method for increasing the survival of dopamine secreting cells |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040180949 conjugates of pharmaceutical agents and a highly lipphilic group, a C22 unbranched carbon chain; render the activity of these compounds selective for colon tissue, breast tissue and central nervous system tissue |
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 09/16/2004 | US20040180434 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180324 Identifying insulin producing beta cell proliferating factor in oocyte fluids for use in treatment of diabetes |
| 09/16/2004 | US20040180321 comprising red blood cells; for treating in vitro/ex vivo using a non-radical cationic group |
| 09/16/2004 | US20040180065 Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer |
| 09/16/2004 | US20040180043 Administering stem cell products to a heart in need of treatment, whereby the stem cells products increase cardiac function thereby treating heart failure and improving cardiac function |
| 09/16/2004 | US20040180042 Graft prosthesis, materials and methods |
| 09/16/2004 | US20040180041 Administering to or transplanting into patient at least one cell or tissue obtained from a cloned ungulate animal or embryo |
| 09/16/2004 | US20040180040 Methods and compositions for directing cells to target organs |
| 09/16/2004 | US20040180037 Use of IL-7 for treating autoimmune diseases, in particular insulin-dependent diabetes mellitus |
| 09/16/2004 | US20040180001 antitumor |
| 09/16/2004 | CA2768008A1 Clostridial neurotoxins for treating uterine disorders |
| 09/16/2004 | CA2518091A1 Dried blood plasma product |
| 09/16/2004 | CA2517982A1 Cell culture |
| 09/16/2004 | CA2517959A1 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
| 09/16/2004 | CA2517916A1 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | CA2517911A1 Composition and method for the treatment and prevention of enteric bacterial infections |
| 09/16/2004 | CA2517287A1 Regulation of t cells by lag-3 (cd223) |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457497A1 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456377A2 Syn3 compositions and methods |
| 09/15/2004 | EP1456374A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |